切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - 5-HT7 Receptors - Aurora Kinases - MER - Angiotensin AT2 Receptors

29件产品中的 1-10

页面
每页
清除全部
  1. UNC2025
    B8016 UNC2025
     1 Citation
    Target: MER|FLT3
    Summary: 口服生物可利用的双重MER/FLT3抑制剂
      ≥23.85 mg/mL
      ≥6.09 mg/mL
  2. G-749
    A8889 G-749
    Target: Aurora Kinases|FLT3|c-RET
    Summary: FLT3抑制剂
      ≥26.05 mg/mL
      insoluble in H2O
  3. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  4. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  5. PD123319
    B2206 PD123319
    Target: Angiotensin AT2 Receptors
    Summary: 血管紧张素AT2受体的拮抗剂
      ≥22.4 mg/mL
      ≥104.2 mg/mL
  6. MK-8745
    A8807 MK-8745
    Target: Aurora Kinases
    Summary: Aurora A的强效选择性抑制剂。
      ≥21.6 mg/mL
      insoluble in H2O
  7. TC-A 2317 hydrochloride
    A4489 TC-A 2317 hydrochloride
    Target: Aurora Kinases
    Summary: Aurora kinase A抑制剂
      <39.29 mg/mL
      <19.65 mg/mL
  8. Vortioxetine
    A3926 Vortioxetine
    中文名: 沃替西汀
    Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT
    Summary: 5-HT受体拮抗剂
      ≥14.92 mg/mL
      insoluble in H2O
  9. Reversine
    A3760 Reversine
    中文名: 逆转素
    Target: Aurora Kinases
    Summary: Aurora激酶抑制剂
      ≥19.65 mg/mL
      insoluble in H2O
  10. PD 123319 ditrifluoroacetate
    A3704 PD 123319 ditrifluoroacetate
    Target: Angiotensin AT2 Receptors
    Summary: 血管紧张素AT2受体拮抗剂
      ≥110.2 mg/mL
      ≥73.7 mg/mL

29件产品中的 1-10

页面
每页